scispace - formally typeset
R

Richard B. Horenstein

Researcher at University of Maryland, Baltimore

Publications -  43
Citations -  5242

Richard B. Horenstein is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Clopidogrel & Platelet aggregation inhibitor. The author has an hindex of 26, co-authored 43 publications receiving 4750 citations. Previous affiliations of Richard B. Horenstein include Johns Hopkins University & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

TL;DR: CYP2C19*2 genotype was associated with diminished platelet response to clopidogrel treatment and poorer cardiovascular outcomes, and patients with the CYP2C 19*2 variant were more likely to have a cardiovascular ischemic event or death during 1 year of follow-up.
Journal ArticleDOI

Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications

TL;DR: The increased expression of A-SAA by adipocytes in obesity suggests that it may play a critical role in local and systemic inflammation and free fatty acid production and could be a direct link between obesity and its comorbidities, such as insulin resistance and atherosclerosis.
Journal ArticleDOI

Loci associated with ischaemic stroke and its subtypes (SiGN) : A genome-wide association study

Sara L. Pulit, +202 more
- 01 Feb 2016 - 
TL;DR: A novel locus (G allele at rs12122341) at 1p13.2 near TSPAN2 that was associated with large artery atherosclerosis-related stroke was identified and supported robust associations with ischaemic stroke for four other loci that have been reported in previous studies.